A ministry expert panel has endorsed an application by SS Pharmaceutical to manufacture and sell Cialis as a nonprescription medicine.

Pending final approval after a public comment period, the drug will become available to men aged 18 and older at pharmacies. Purchases will require face-to-face guidance from pharmacists to ensure proper use and safety.

Supporters of wider access argue that erectile dysfunction is a contributing factor to infertility. They emphasize that improving the availability of treatments like Cialis is essential to address this issue.

The ministry has been reviewing the matter carefully in response to these calls, weighing the benefits of increased accessibility alongside necessary safety considerations.
https://newsonjapan.com/article/146945.php